Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03101475
Title Synergism of Immunomodulation and Tumor Ablation (ILOC)
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements No
Sponsors European Organisation for Research and Treatment of Cancer - EORTC
Indications
Therapies
Age Groups: senior | adult
Covered Countries NLD | FRA | DEU | AUT


No variant requirements are available.